DeLong RK - Search Results

1

The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments.

Sasso JM, Ambrose BJB, Tenchov R, Datta RS, Basel MT, DeLong RK, Zhou QA. Sasso JM, et al. Among authors: delong rk. J Med Chem. 2022 May 26;65(10):6975-7015. doi: 10.1021/acs.jmedchem.2c00024. Epub 2022 May 9. J Med Chem. 2022. PMID: 35533054 Free PMC article. Review.

2

Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.

DeLong RK, Curtis CB. DeLong RK, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Mar;9(2):10.1002/wnan.1415. doi: 10.1002/wnan.1415. Epub 2016 Jun 16. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. PMID: 27312869 Free PMC article. Review.

3

Engineering the RNA-Nanobio Interface.

Murthy V, Delong RK. Murthy V, et al. Among authors: delong rk. Bioengineering (Basel). 2017 Feb 15;4(1):13. doi: 10.3390/bioengineering4010013. Bioengineering (Basel). 2017. PMID: 28952492 Free PMC article. Review.

4

Comparative Molecular Immunological Activity of Physiological Metal Oxide Nanoparticle and its Anticancer Peptide and RNA Complexes.

DeLong RK, Comer J, Mathew EN, Jaberi-Douraki M. DeLong RK, et al. Nanomaterials (Basel). 2019 Nov 22;9(12):1670. doi: 10.3390/nano9121670. Nanomaterials (Basel). 2019. PMID: 31771091 Free PMC article.

5

Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer.

DeLong RK, Cheng YH, Pearson P, Lin Z, Coffee C, Mathew EN, Hoffman A, Wouda RM, Higginbotham ML. DeLong RK, et al. J Pharmacol Exp Ther. 2019 Sep;370(3):671-681. doi: 10.1124/jpet.118.256230. Epub 2019 Apr 30. J Pharmacol Exp Ther. 2019. PMID: 31040175 Free PMC article. Review.

6

Enzyme Nanoscale Interactions with Manganese Zinc Sulfide Give Insight into Potential Antiviral Mechanisms and SARS-CoV-2 Inhibition.

DeLong RK, Huber H, Aparicio-Lopez C, Bhatti A, Swanson R, Shrestha TB, Gaudreault NN. DeLong RK, et al. ACS Pharmacol Transl Sci. 2022 Jun 22;5(7):449-457. doi: 10.1021/acsptsci.2c00041. eCollection 2022 Jul 8. ACS Pharmacol Transl Sci. 2022. PMID: 35821747 Free PMC article.

7

Enhancing RNA Payload and Temperature Stability and Activity with Cationic Peptide-Coated Zinc Oxide Nanoparticles.

DeLong RK, Nava-Chavez J, Kumar R, Mathew EN, Mwangi W, Yoon S. DeLong RK, et al. ACS Pharmacol Transl Sci. 2024 Feb 7;7(3):707-715. doi: 10.1021/acsptsci.3c00280. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481696

8

Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interference.

Mathew EN, Hurst MN, Wang B, Murthy V, Zhang Y, DeLong RK. Mathew EN, et al. Among authors: delong rk. PLoS One. 2020 Dec 16;15(12):e0243802. doi: 10.1371/journal.pone.0243802. eCollection 2020. PLoS One. 2020. PMID: 33326476 Free PMC article.

9

Ushering in a new era of RNA-based therapies.

DeLong R. DeLong R. Commun Biol. 2021 May 17;4(1):577. doi: 10.1038/s42003-021-02150-w. Commun Biol. 2021. PMID: 34002014 Free PMC article.

10

Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates.

Huber HF, Jaberi-Douraki M, DeVader S, Aparicio-Lopez C, Nava-Chavez J, Xu X, Millagaha Gedara NI, Gaudreault NN, Delong RK. Huber HF, et al. Among authors: delong rk. Pharmaceuticals (Basel). 2021 Oct 1;14(10):1012. doi: 10.3390/ph14101012. Pharmaceuticals (Basel). 2021. PMID: 34681236 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page